Antipsychotics for ICU Delirium: No Gain in Delirium- or Coma-Free Days
This five-trial meta-analysis of 1750 patients tests antipsychotics as a class for ICU delirium treatment and gives pharmacists a consolidated basis for deprescribing and stewardship decisions.
📅 Journal publication: Jul 1, 2024(online Mar 15, 2024)·Last updated: Nov 10, 2026
haloperidolquetiapineziprasidoneantipsychoticsdeliriumcritical careICUmeta-analysissystematic reviewtrial sequential analysismortalitymechanical ventilationCritical Care / ICU
Background Information
Antipsychotics show limited efficacy in treating ICU delirium.
Delirium in critically ill patients can lead to worse outcomes, and understanding effective treatments is crucial for improving patient care. The meta-analysis found no significant benefit of antipsychotics in reducing delirium duration or mortality in ICU patients. With limited efficacy shown for antipsychotics, alternative strategies for delirium management in the ICU may be needed. Further research is warranted. Antipsychotics do not significantly improve delirium outcomes in ICU patients.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Carayannopoulos KL, Alshamsi F, Chaudhuri D, Spatafora L, Piticaru J, Campbell K, Alhazzani W, Lewis K
Citation:Carayannopoulos KL, Alshamsi F, Chaudhuri D, et al. Antipsychotics in the Treatment of Delirium in Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Critical care medicine. 2024;52(7):1087-1096. doi:10.1097/CCM.0000000000006251